A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding
- 31 July 2007
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 44 (14) , 3510-3516
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3bImmunology, 2003
- Role of the Fcγ receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: A meta‐analysisArthritis & Rheumatism, 2002
- Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele.Journal of Experimental Medicine, 1989
- Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.Journal of Experimental Medicine, 1988
- Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1.Journal of Experimental Medicine, 1988
- A study of the structure of human complement component factor H by Fourier transform infrared spectroscopy and secondary structure averaging methodsBiochemistry, 1988
- Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseasesArthritis & Rheumatism, 1988
- The erythrocyte–immune complex–glomerulonephritis connection in manKidney International, 1987
- Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.Journal of Experimental Medicine, 1987
- Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus.Journal of Experimental Medicine, 1984